Exposure to infant siblings during early life and risk of multiple sclerosis

JAMA

Volumn 293, Issue 4, 2005, Pages 463-469

  Ponsonby, Anne Louise ^a,b   Van Der Mei, Ingrid ^b   Dwyer, Terence ^b   Blizzard, Leigh ^b   Taylor, Bruce ^c   Kemp, Andrew ^d   Simmons, Rex ^e   Kilpatrick, Trevor ^f  

^a The Australian National University   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c ROYAL HOBART HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e CANBERRA HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; EPSTEIN BARR VIRUS; EXPOSURE; FEMALE; HUMAN; IMMUNE RESPONSE; INFANCY; INFECTION RISK; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIBLING; VIRUS INFECTION;

EID: 12544258106     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.4.463     Document Type: Article

References (42)

1. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.
2. Isager H, Andersen E, Hyllested K. Risk of multiple sclerosis inversely associated with birth order position. Acta Neurol Scand. 1980;61:393-396.
3. Visscher BR, Liu KS, Sullivan C, Valdiviezo NL, Detels R. Birth order and multiple sclerosis. Acta Neurol Scand. 1982;66:209-215.
4. Zilber N, Kutai-Berman M, Kahana E, Korczyn AD. Multiple sclerosis and birth order. Acta Neurol Scand. 1988;78:313-317.
5. Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology. 2001;12:301-306.
6. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Acta Neurol Scand. 1989;124:S1-S123.
7. Matias-Guiu J, Ferri L, Falip R, Galiano L, Martin R. Birth order in multiple sclerosis: a population-based case-control study in Alcoi, Spain. Neuroepidemiology. 1994; 13:129-130.
8. Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis. 1983;148:200-205.
9. Adams CL, MacLeod MK, James Milner-White E, Aitken R, Garside P, Stott DI. Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology. 2003;108:274-287.
10. Amyes E, Hatton C, Montamat-Sicotte D, et al. Characterisation of the CD4+ T cell response to Esptein-Barr virus during primary and persistent infection. J Exp Med. 2003;198:903-911.
11. Wedderburn LR, Patel A, Varsani H, Woo P. The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology. 2001;102:301-309.
12. Leibowitz U, Antonovsky A, Medalie J, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel, II: multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry. 1966;29: 60-68.
13. Haahr S, Koch-Henriksen N, Moller-Larsen A, Eriksen LS, Andersen HM. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler. 1995;1:73-77.
14. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001;286:3083-3088.
15. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus. JAMA. 2003;289: 1533-1536.
16. Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol. 2001;154:69-74.
17. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60-65.
18. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ. 2003;327:316.
19. Ullrich SE. Photoimmune suppression and photocarcinogenesis. Front Biosci. 2002;7:684-703.
20. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38:180-185.
21. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
22. Rubio JP, Bahlo M, Butzkueven H, et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet. 2002;70:1125-1137.
23. Gartner BC, Hess RD, Bandt D, et al. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol. 2003;10:78-82.
24. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet. 1994;344:456-458.
25. Knipe DM, Howley PM, eds. Fields Virology. Vol 2, 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001.
26. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons Inc; 2000:146, 243-258.
27. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co; 1986:150.
28. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002; 360:678-682.
29. Dagan R, Fraser D, Handsher R. Acquisition of immunity in mothers of infants administered bivalent oral poliovirus vaccine. Eur J Clin Miocrobiol Infect Dis. 1994; 13:1029-1032.
30. Farr TJ, Harnett GB, Pietroboni GR, Bucens MR. The distribution of antibodies to HHV-6 compared with other herpesviruses in young children. Epidemiol Infect. 1990;105:603-607.
31. Villoslada P, Juste C, Tintore M, et al. The immune response against herpesvirus is more prominent in the early stages of MS. Neurology. 2003;60: 1944-1948.
32. Kim BS, Lyman MA, Kang BS, et al. Pathogenesis of virus-induced immune-mediated demyelination. Immunol Res. 2001;24:121-130.
33. Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA. 2004;291:1875-1879.
34. Aalto SM, Linnavuori K, Peltola H, et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol. 1998;56:189-191.
35. Huang LM, Lee CY, Chang MH, Wang JD, Hsu CY. Primary infections of Epstein-Barr virus, cytomegalovirus and human herpesvirus-6. Arch Dis Child. 1993;68:408-411.
36. Cuomo L, Angeloni A, Zompetta C, et al. Human herpesvirus 6 variant A, but not variant B, infects EBV-positive lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism. AIDS Res Hum Retroviruses. 1995;11: 1241-1245.
37. Savoldo B, Cubbage ML, Durett AG, et al. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002;168:909-918.
38. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695-705.
39. Olson JK, Eagar TN, Miller SD. Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol. 2002;169:2719-2726.
40. Hollsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol. 2003;132:137-143.
41. Wing K, Lindgren S, Kollberg G, et al. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur J Immunol. 2003;33:579-587.
42. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Nature. 1995;377:150-151.